Early atrophy of pallidum and accumbens nucleus in Huntington’s disease
Authors:
- TRACK-HD Investigator GroupTGTRACK-HD Investigator Group
- Simon J. A. van Den BogaardSBSimon J. A. van Den Bogaard
- Hans JohnsonHJHans Johnson
- Douglas R. LangbehnDLDouglas R. Langbehn
- Rachael I. ScahillRSRachael I. Scahill
- Sarah J. TabriziSTSarah J. Tabrizi
- Mark A. BuchemMBMark A. Buchem
- Jeroen GrondJGJeroen Grond
Open Access
- 9 October 2010
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 258 (3) , 412-420
Abstract
In Huntington’s disease (HD) atrophy of the caudate nucleus and putamen has been described many years before clinical manifestation. Volume changes of the pallidum, thalamus, brainstem, accumbens nucleus, hippocampus, and amygdala are less well investigated, or reported with contradicting results. The aim of our study is to provide a more precise view of the specific atrophy of the subcortical grey matter structures in different stages of Huntington’s disease, and secondly to investigate how this influences the clinical manifestations. All TRACK-HD subjects underwent standardised T1-weighted 3T MRI scans encompassing 123 manifest HD (stage 1, n = 77; stage 2, n = 46), 120 premanifest HD (close to onset n = 58, far from onset n = 62) and 123 controls. Using FMRIB’s FIRST and SIENAX tools the accumbens nucleus, amygdala, brainstem, caudate nucleus, hippocampus, pallidum, putamen, thalamus and whole brain volume were extracted. Results showed that volumes of the caudate nucleus and putamen were reduced in premanifest HD far from predicted onset (>10.8 years). Atrophy of accumbens nucleus and pallidum was apparent in premanifest HD in the close to onset group (0–10.8 years). All other structures were affected to some degree in the manifest group, although brainstem, thalamus and amygdala were relatively spared. The accumbens nucleus, putamen, pallidum and hippocampus had a strong significant correlation with functional and motor scores. We conclude that volume changes may be a sensitive and reliable measure for early disease detection and in this way serve as a biomarker for Huntington’s disease. Besides the caudate nucleus and putamen, the pallidum and the accumbens nucleus show great potential in this respect.Keywords
This publication has 37 references indexed in Scilit:
- Onset and rate of striatal atrophy in preclinical Huntington diseaseNeurology, 2004
- Advances in functional and structural MR image analysis and implementation as FSLNeuroImage, 2004
- When does Huntington's disease begin?Journal of the International Neuropsychological Society, 1998
- Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumesBrain, 1997
- CAG repeat number governs the development rate of pathology in Huntington's diseaseAnnals of Neurology, 1997
- Basal Ganglia Volume and Proximity to Onset in Presymptomatic Huntington DiseaseArchives of Neurology, 1996
- Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk personsNeurology, 1994
- Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's diseaseAnnals of Neurology, 1992
- Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseasesBiological Psychiatry, 1991
- Huntington diseaseNeurology, 1979